These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


208 related items for PubMed ID: 15816513

  • 21. Tumor detection using folate receptor-targeted imaging agents.
    Sega EI, Low PS.
    Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
    [Abstract] [Full Text] [Related]

  • 22. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates.
    Reddy JA, Westrick E, Vlahov I, Howard SJ, Santhapuram HK, Leamon CP.
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):229-36. PubMed ID: 16331500
    [Abstract] [Full Text] [Related]

  • 23. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
    Gibbs DD, Theti DS, Wood N, Green M, Raynaud F, Valenti M, Forster MD, Mitchell F, Bavetsias V, Henderson E, Jackman AL.
    Cancer Res; 2005 Dec 15; 65(24):11721-8. PubMed ID: 16357184
    [Abstract] [Full Text] [Related]

  • 24. In vivo structural activity and optimization studies of folate-tubulysin conjugates.
    Reddy JA, Dorton R, Dawson A, Vetzel M, Parker N, Nicoson JS, Westrick E, Klein PJ, Wang Y, Vlahov IR, Leamon CP.
    Mol Pharm; 2009 Dec 15; 6(5):1518-25. PubMed ID: 19630399
    [Abstract] [Full Text] [Related]

  • 25. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.
    Moon WK, Lin Y, O'Loughlin T, Tang Y, Kim DE, Weissleder R, Tung CH.
    Bioconjug Chem; 2003 Dec 15; 14(3):539-45. PubMed ID: 12757377
    [Abstract] [Full Text] [Related]

  • 26. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P, Stein R, Pickett J, Qu Z, Govindan SV, Cardillo TM, Hansen HJ, Horak ID, Griffiths GL, Goldenberg DM.
    Clin Cancer Res; 2005 Jul 15; 11(14):5257-64. PubMed ID: 16033844
    [Abstract] [Full Text] [Related]

  • 27. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
    Sega EI, Lu Y, Ringor M, Leamon CP, Low PS.
    Int J Radiat Oncol Biol Phys; 2008 Jun 01; 71(2):559-66. PubMed ID: 18411004
    [Abstract] [Full Text] [Related]

  • 28. [Anticancer activity of N-(phenylacetyl) doxorubicin combined with folate-targeted PGA].
    Zhang Q, Xiang GY, Long N, Lin JL, Zeng FB.
    Yao Xue Xue Bao; 2005 Nov 01; 40(11):1046-50. PubMed ID: 16499093
    [Abstract] [Full Text] [Related]

  • 29. Maternal folate deficiency results in selective upregulation of folate receptors and heterogeneous nuclear ribonucleoprotein-E1 associated with multiple subtle aberrations in fetal tissues.
    Xiao S, Hansen DK, Horsley ET, Tang YS, Khan RA, Stabler SP, Jayaram HN, Antony AC.
    Birth Defects Res A Clin Mol Teratol; 2005 Jan 01; 73(1):6-28. PubMed ID: 15641086
    [Abstract] [Full Text] [Related]

  • 30. Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.
    Smith-Jones PM, Pandit-Taskar N, Cao W, O'Donoghue J, Philips MD, Carrasquillo J, Konner JA, Old LJ, Larson SM.
    Nucl Med Biol; 2008 Apr 01; 35(3):343-51. PubMed ID: 18355690
    [Abstract] [Full Text] [Related]

  • 31. Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody.
    Yao Z, Garmestani K, Wong KJ, Park LS, Dadachova E, Yordanov A, Waldmann TA, Eckelman WC, Paik CH, Carrasquillo JA.
    J Nucl Med; 2001 Oct 01; 42(10):1538-44. PubMed ID: 11585870
    [Abstract] [Full Text] [Related]

  • 32. Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays.
    Larsen RH, Bruland OS, Hoff P, Alstad J, Lindmo T, Rofstad EK.
    Radiat Res; 1994 Aug 01; 139(2):178-84. PubMed ID: 8052693
    [Abstract] [Full Text] [Related]

  • 33. Derlin-1 is overexpressed on the tumor cell surface and enables antibody-mediated tumor targeting therapy.
    Ran Y, Hu H, Hu D, Zhou Z, Sun Y, Yu L, Sun L, Pan J, Liu J, Liu T, Yang Z.
    Clin Cancer Res; 2008 Oct 15; 14(20):6538-45. PubMed ID: 18927294
    [Abstract] [Full Text] [Related]

  • 34. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.
    Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker JR.
    Cancer Res; 2005 Jun 15; 65(12):5317-24. PubMed ID: 15958579
    [Abstract] [Full Text] [Related]

  • 35. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
    Lu Y, Sega E, Leamon CP, Low PS.
    Adv Drug Deliv Rev; 2004 Apr 29; 56(8):1161-76. PubMed ID: 15094213
    [Abstract] [Full Text] [Related]

  • 36. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 13; 87(10):673-8. PubMed ID: 17553304
    [Abstract] [Full Text] [Related]

  • 37. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
    Shankar S, Vaidyanathan G, Kuan CT, Bigner DD, Zalutsky MR.
    Nucl Med Biol; 2006 Jan 13; 33(1):101-10. PubMed ID: 16459265
    [Abstract] [Full Text] [Related]

  • 38. Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors.
    Vlashi E, Sturgis JE, Thomas M, Low PS.
    Mol Pharm; 2009 Jan 13; 6(6):1868-75. PubMed ID: 19754150
    [Abstract] [Full Text] [Related]

  • 39. Selective targeting of malignant cells with cytotoxin-folate conjugates.
    Leamon CP, Low PS.
    J Drug Target; 1994 Jan 13; 2(2):101-12. PubMed ID: 8069588
    [Abstract] [Full Text] [Related]

  • 40. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
    Yamada A, Taniguchi Y, Kawano K, Honda T, Hattori Y, Maitani Y.
    Clin Cancer Res; 2008 Dec 15; 14(24):8161-8. PubMed ID: 19088031
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.